3 completed, 2 terminated. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 3, Terminated 2 |
Follow Hemin: new trials by email Literature Review of Hemin trials Research Report on Hemin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Panhematin for Prevention of Acute Attacks of Porphyria Hemin for injection, Placebo - Acute Intermittent Porphyria, Hereditary Coproporphyria | Phase 2 | Terminated | The University of Texas Medical Branch, Galveston | 13 | 2015-10-30 | 2026-01-30 |
| Controlled Trial of Panhematin in Treatment of Acute Attacks of Porphyria Panhematin, Glucose - Acute Porphyrias | Phase 2 | Completed | The University of Texas Medical Branch, Galveston | 20 | 2014-04-28 | 2025-04-11 |
| Hemin to Prevent Post-ERCP (Endoscopic Retrograde Cholangiopancreatography) Acute Pancreatitis Hemin, placebo - Post-ERCP Acute Pancreatitis | Phase 2 | Completed | Erasme University Hospital | 284 | 2012-04-01 | 2021-07-07 |
| A Pilot Study of Hemin Therapy for Gastroparesis (Diabetes Mellitus) Hemin, Albumin - Gastroparesis, Diabetes Mellitus | Phase 2 | Completed | Mayo Clinic | 20 | 2010-05-01 | 2016-02-04 |
| Phase 2, Open-Label, Multi-Dose Study of Panhematin in Patients With MDS Panhematin - Myelodysplastic Syndrome | Phase 2 | Terminated | Rush University Medical Center | 6 | 2007-05-01 | 2014-10-24 |
Porphyria, Acute Intermittent (2) · Coproporphyria, Hereditary (1) · Diabetes Mellitus (1) · Gastroparesis (1) · Myelodysplastic Syndromes (1) · Porphyria, Variegate (1) · Porphyrias (1)
The University of Texas Medical Branch, Galveston (2) · Erasme University Hospital (1) · Mayo Clinic (1) · Rush University Medical Center (1)
United States (4) · Belgium (1) · Taiwan (1)
Karl E Anderson, MD (2) · Adil E Bharucha, MBBS, MD (1) · Arnaud Lemmers, MD,PhD (1) · Jamile Shammo, MD (1)
P01DK068055 (1), UL1TR000135 (1)